We are live on ! Find out more
BC

BIT Capital Portfolio holdings

AUM $2.07B
1-Year Est. Return 157.17%
This Fund
S&P 500
This Quarter Est. Return
+16.08%
1 Year Est. Return
+157.17%
3 Year Est. Return
+781.63%
5 Year Est. Return
+899.06%
10 Year Est. Return
AUM
$1.28B
AUM Growth
-$71.7M
Cap. Flow
-$170M
Cap. Flow %
-13.32%
Top 10 Hldgs %
58.87%
Holding
132
New
24
Increased
25
Reduced
34
Closed
30

Top Buys

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$93.5M
2
TSM icon
TSMC
TSM
+$26.9M
3
MU icon
Micron Technology
MU
+$20.9M
4
HIMS icon
Hims & Hers Health
HIMS
+$17.5M
5
MSFT icon
Microsoft
MSFT
+$15.1M

Top Sells

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$48.7M
2
META icon
Meta Platforms (Facebook)
META
+$40.2M
3
IREN icon
Iris Energy
IREN
+$32.1M
4
AFRM icon
Affirm
AFRM
+$28.9M
5
TSLA icon
Tesla
TSLA
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 34.54%
2 Financials 22.86%
3 Healthcare 14.97%
4 Consumer Discretionary 8.48%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLD icon
76
Applied Digital
APLD
$7.37B
$1.04M 0.08%
175,052
-105,034
-38% -$408K
PRCT icon
77
Procept Biorobotics
PRCT
$1.09B
$1.04M 0.08%
+17,025
New +$1.01M
KROS icon
78
Keros Therapeutics
KROS
$211M
$1.04M 0.08%
22,738
+10,795
+90% +$580K
IBKR icon
79
Interactive Brokers
IBKR
$40.3B
$1.03M 0.08%
+33,568
New +$1M
LILMW
80
DELISTED
Lilium N.V. Warrants
LILMW
$1.02M 0.08%
12,442,384
+10,327,000
+488% +$1.07M
BFH icon
81
Bread Financial
BFH
$4.01B
$1.02M 0.08%
+22,803
New +$894K
CLSK icon
82
CleanSpark
CLSK
$3.34B
$862K 0.07%
54,050
-134,075
-71% -$2.25M
ANRO icon
83
Alto Neuroscience
ANRO
$1.07B
$851K 0.07%
79,562
JPM icon
84
JPMorgan Chase
JPM
$907B
$829K 0.06%
4,101
-33,083
-89% -$6.47M
SWTX
85
DELISTED
SpringWorks Therapeutics
SWTX
$792K 0.06%
+21,020
New +$885K
LMT icon
86
Lockheed Martin
LMT
$117B
$782K 0.06%
1,675
AAPL icon
87
Apple
AAPL
$4.9T
$768K 0.06%
+3,648
New +$680K
VIRT icon
88
Virtu Financial
VIRT
$4.85B
$737K 0.06%
+32,820
New +$732K
VTYX
89
DELISTED
Ventyx Biosciences
VTYX
$704K 0.06%
304,760
+124,052
+69% +$515K
ATNM icon
90
Actinium Pharmaceuticals
ATNM
$28.9M
$664K 0.05%
89,668
CRDF icon
91
Cardiff Oncology
CRDF
$60.2M
$656K 0.05%
295,518
+59,339
+25% +$224K
OPTN
92
DELISTED
OptiNose
OPTN
$649K 0.05%
+41,600
New +$697K
TNYA icon
93
Tenaya Therapeutics
TNYA
$177M
$622K 0.05%
200,668
KURA icon
94
Kura Oncology
KURA
$964M
$621K 0.05%
30,184
AUTL
95
Autolus Therapeutics
AUTL
$383M
$609K 0.05%
174,987
-34,491
-16% -$149K
LX
96
LexinFintech Holdings
LX
$254M
$589K 0.05%
357,042
-313,875
-47% -$556K
HOWL icon
97
Werewolf Therapeutics
HOWL
$17.9M
$569K 0.04%
+233,370
New +$1.12M
SOFI icon
98
SoFi Technologies
SOFI
$22.2B
$479K 0.04%
72,486
-1,412,391
-95% -$9.96M
MRUS
99
DELISTED
Merus
MRUS
$473K 0.04%
8,000
OPEN icon
100
Opendoor
OPEN
$4.34B
$268K 0.02%
150,475
+150,330
+103,676% +$324K

Similar funds

BIT Capital's Q2 2024 Portfolio in Review

As of Q2 2024, BIT Capital held 132 positions worth $1.28B, down 5.3% from $1.35B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

BIT Capital withdrew a net $170M in Q2 2024, closing 30 positions and reducing 34 holdings. Its most notable exit was Tesla, an estimated $27.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BIT Capital opened a new position in Duolingo worth $95.3M.

  • BIT Capital's largest Q2 2024 buy was Duolingo: 456,511 shares worth $95.3M.
  • BIT Capital added most to TSMC in Q2 2024, an estimated $26.9M increase.
  • BIT Capital's biggest Q2 2024 reduction was Coinbase, cutting an estimated $48.7M.
  • BIT Capital fully exited Tesla in Q2 2024, selling an estimated $27.7M.
  • BIT Capital's ten largest holdings make up 59% of its $1.28B portfolio in Q2 2024.
  • BIT Capital opened 24 new positions and closed 30 in Q2 2024.
  • BIT Capital's portfolio value fell 5.3% quarter-over-quarter to $1.28B.

Based on BIT Capital's 13F filing for Q2 2024, filed 12 Feb 2025.